Zelira Therapeutics Limited
ZLDAF
$0.2992
$0.041616.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 86.60% | 1.97% | -537.46% | -344.48% | -240.52% |
| Total Depreciation and Amortization | -32.43% | -22.64% | -14.47% | -13.96% | -12.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -108.61% | 3.15% | 1,040.17% | 4,512.34% | 1,472.05% |
| Change in Net Operating Assets | 95.32% | 95.32% | 95.32% | 1,614.80% | 218.24% |
| Cash from Operations | 2.96% | 24.21% | 40.98% | 40.10% | 38.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.33% | -61.74% | -68.26% | -22.82% | 160.44% |
| Cash from Investing | -52.33% | -61.74% | -68.26% | -22.82% | 160.44% |
| Total Debt Issued | 161.94% | 397.79% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -56.56% | -23.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.90% | 57.00% | 115.27% | 300.28% | -- |
| Foreign Exchange rate Adjustments | -227.27% | -171.43% | -130.03% | -108.11% | -102.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.81% | 115.17% | 116.63% | 103.51% | 99.15% |